Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration

Clotilde Lagier-Tourenne, Michael Baughn, Frank Rigo, Shuying Sun, Patrick Liu, Hai Ri Li, Jie Jiang, Andrew T. Watt, Seung Chun, Melanie Katz, J. Qiu, Ying Sun, Shuo Chien Ling, Qiang Zhu, Magdalini Polymenidou, Kevin Drenner, Jonathan W. Artates, Melissa McAlonis-Downes, Sebastian Markmiller, Kasey R. HuttDonald P. Pizzo, J. Cady, Matthew B. Harms, Robert H. Baloh, Scott R. Vandenberg, Gene W. Yeo, Xiang Dong Fu, C. Frank Bennett, Don W. Cleveland, J. Ravits

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration'. Together they form a unique fingerprint.

Medicine & Life Sciences